We previously demonstrated that LSD1 inhibition reactivates RA-induced differentiation in leukemia, which made us hypothesize that combination of verlindamycin and all-trans-retinoic acid (ATRA) can also be effective in neuroblastoma [14]. Here, KDM1A is linked to neuroblastoma.